综合基因组网络分析揭示了潜在的药物治疗治疗治疗的目标
Wirawan Adikusuma1,2, Firdayani Firdayani2, Lalu Muhammad Irham3
1Departement of Pharmacy, University of Muhammadiyah Mataram, Mataram, Indonesia.
概括
这项研究使用生物信息学确定了用于治疗的新药候选者. 它强调NOX1和NOS3基因是潜在的生物标志物,NOS3对向疗法显示出重大前景.
科学领域:
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 很常见,但有效的治疗方法有限.
- 目前的选择包括口服药物,局部应用和手术.
- 基因标记物为新的治疗提供了潜在的潜力.
研究的目的:
- 为了确定用于治疗的新药候选者.
- 为了药物发现,利用生物信息学和基因组网络分析.
- 为了探索个性化干预的遗传生物标志物.
主要方法:
- 使用DrugBank从293个相关基因中提取了21个可药物治疗的基因.
- 根据基因标选择了87种潜在药物.
- 综合基因组网络分析与生物信息学方法.
主要成果:
- 确定了84种新型化合物和3种重新使用的药物 (胺,甲蓝,富尔韦斯特兰特) 用于治疗.
- 突出了NOX1和NOS3基因作为有前途的生物标志物.
- 由于其全身功能注释,发现NOS3具有重要意义,而Sapropterin是潜在的相关药物.
结论:
- 生物信息学和基因组网络分析可以有效地将药物用于治疗.
- NOS3是针对性干预的重要生物标志物.
- 进一步的研究应该调查NOS3向治疗的机制.
相关概念视频
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K


